Cargando…
Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis
The major challenges in pancreatic ductal adenocarcinoma (PDAC) management are local or distant metastasis and limited targeted therapeutics to prevent it. To identify a druggable target in tumor secretome and to explore its therapeutic intervention, we performed a liquid chromatography–tandem mass...
Autores principales: | Choi, Yeon-Sook, Kim, Myung Ji, Choi, Eun A., Kim, Sinae, Lee, Eun ji, Park, Min Ji, Kim, Mi-Ju, Kim, Yeon Wook, Ahn, Hee-Sung, Jung, Jae Yun, Jang, Gayoung, Kim, Yongsub, Kim, Hyori, Kim, Kyunggon, Kim, Jin Young, Hong, Seung-Mo, Kim, Song Cheol, Chang, Suhwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335190/ https://www.ncbi.nlm.nih.gov/pubmed/35858411 http://dx.doi.org/10.1073/pnas.2119048119 |
Ejemplares similares
-
siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model
por: Jung, Jae Yun, et al.
Publicado: (2021) -
Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge
por: Jung, Jaeyun, et al.
Publicado: (2015) -
A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants
por: Kweon, Jiyeon, et al.
Publicado: (2019) -
A drug‐repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6‐thioguanine as an effective therapeutic agent for TPMT‐low cancer cells
por: Kim, Inki, et al.
Publicado: (2018) -
Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
por: Kang, Hyeon Gu, et al.
Publicado: (2022)